A detailed history of Keudell transactions in Astrazeneca PLC stock. As of the latest transaction made, Keudell holds 4,596 shares of AZN stock, worth $301,635. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,596
Previous 4,674 1.67%
Holding current value
$301,635
Previous $364,000 1.65%
% of portfolio
0.1%
Previous 0.11%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$76.67 - $87.62 $5,980 - $6,834
-78 Reduced 1.67%
4,596 $358,000
Q2 2024

Jul 16, 2024

BUY
$66.81 - $80.83 $200 - $242
3 Added 0.06%
4,674 $364,000
Q1 2024

May 07, 2024

BUY
$61.03 - $69.57 $183 - $208
3 Added 0.06%
4,671 $316,000
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $23,146 - $25,910
374 Added 8.71%
4,668 $314,000
Q3 2023

Oct 18, 2023

BUY
$64.85 - $71.7 $843 - $932
13 Added 0.3%
4,294 $290,000
Q1 2023

Apr 18, 2023

BUY
$63.15 - $71.6 $5,746 - $6,515
91 Added 2.17%
4,281 $297,000
Q4 2022

Jan 20, 2023

SELL
$54.21 - $70.44 $7,480 - $9,720
-138 Reduced 3.19%
4,190 $0
Q3 2022

Oct 12, 2022

BUY
$53.02 - $135.75 $3,499 - $8,959
66 Added 1.55%
4,328 $237,000
Q2 2022

Jul 18, 2022

SELL
$59.26 - $71.14 $12,740 - $15,295
-215 Reduced 4.8%
4,262 $282,000
Q1 2022

Apr 18, 2022

SELL
$55.72 - $67.12 $47,194 - $56,850
-847 Reduced 15.91%
4,477 $297,000
Q4 2021

Feb 08, 2022

BUY
$54.02 - $63.83 $20,311 - $24,000
376 Added 7.6%
5,324 $310,000
Q3 2021

Oct 20, 2021

SELL
$55.56 - $60.79 $166 - $182
-3 Reduced 0.06%
4,948 $297,000
Q2 2021

Jul 13, 2021

SELL
$48.42 - $60.18 $11,572 - $14,383
-239 Reduced 4.61%
4,951 $297,000
Q1 2021

Apr 13, 2021

SELL
$47.16 - $54.44 $20,750 - $23,953
-440 Reduced 7.82%
5,190 $258,000
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $21,494 - $25,702
-443 Reduced 7.29%
5,630 $281,000
Q3 2020

Oct 20, 2020

BUY
$53.07 - $61.1 $6,580 - $7,576
124 Added 2.08%
6,073 $333,000
Q2 2020

Jul 14, 2020

BUY
$43.1 - $55.31 $4,913 - $6,305
114 Added 1.95%
5,949 $315,000
Q1 2020

Apr 20, 2020

BUY
$37.79 - $51.33 $34,124 - $46,350
903 Added 18.31%
5,835 $261,000
Q4 2019

Jan 29, 2020

SELL
$42.46 - $50.46 $5,519 - $6,559
-130 Reduced 2.57%
4,932 $246,000
Q3 2019

Nov 13, 2019

SELL
$40.12 - $45.47 $34,503 - $39,104
-860 Reduced 14.52%
5,062 $226,000
Q2 2019

Aug 23, 2019

BUY
$37.28 - $41.68 $220,772 - $246,828
5,922 New
5,922 $260,000
Q2 2019

Aug 21, 2019

SELL
$37.28 - $41.68 $217,864 - $243,577
-5,844 Closed
0 $0
Q1 2019

Aug 21, 2019

BUY
$35.49 - $43.02 $207,403 - $251,408
5,844 New
5,844 $236,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.